CLSDQ.D

Clearside Biomedical, Inc.

Healthcare · Biotechnology

$68.78 sample

+0.46 (+0.67%) 1D

Market cap

$225.5B

Price as of

2026-10-24

Latest filing

8-K · 2026-10-14

Alerts

8

Price$68.78 +11.13% 3M daily closessample

68.7860.14

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 14SECForm 144 filed
Oct 09INSInsider sell: EVP, Operations
Oct 05INSInsider sell: 10% owner
Sep 24INSInsider sell: Director
Sep 16INSInsider sell: Director
Sep 08INSInsider buy: General Counsel
Aug 28INSInsider buy: 10% owner
Aug 21INSInsider sell: Chief Financial Officer

Sign up to see the real CLSDQ.D record →

Company facts

SEC EDGAR registration

Name: Clearside Biomedical, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -13sample, -100 to +100
Reporting currency: USD

Who is positioning in CLSDQ.D

sample

Insiders: 23 insider transactions over 90 days, net selling, $876.2M
Congress: 4 members traded over 90 days
Institutions · 13F: 7 funds hold $2.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$13.9B +15.1% y/y

Q4 2024Q3 2026

Inventory$8.6B +10.8% y/y

Q4 2024Q3 2026

Accounts receivable$6.1B +7.0% y/y

Q4 2024Q3 2026

Total debt$16.7B +13.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $43.3B +7.8% 3M
Sample peer B: $213.7B -6.1% 3M
Sample peer C: $31.4B +6.0% 3M
Sample peer D: $33.6B -3.9% 3M
Sample peer E: $156.9B +8.9% 3M